Kenneth Pienta

CUE

Kenneth Pienta serves as Chief Medical Officer at Cue Biopharma, Inc. (CUE). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$202.9K

Net Position

Net Seller

$202.9K

Companies Traded

CUE

Active Period

Mar 2021

1 total trades

Most Recent

Sell CUE

Mar 15, 2021 · $202.9K

Kenneth Pienta's Insider Trading at Cue Biopharma, Inc. (CUE)

Buys

0 · $0.00

Sells

1 · $202.9K

Total Shares Bought

Total Shares Sold

13,439

CUE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 15, 2021	Sell	13,439	$15.10	$202.9K	0

Related Insiders

Meluzio Michael Vincent

officer: VP, Prin. Accounting Officer

CUESell · Aug 17, 2026

Sumita Ray

officer, other: Chief Legal Compliance Officer

CUESell · Aug 17, 2026

Shao-Lee Lin

director, officer: Chief Executive Officer

CUESell · Aug 14, 2026

Pasha Sarraf

Director

CUEBuy · Dec 30, 2025

Explore More Insider Trading Data

CUE Insider Trading Activity

View all insider trades at Cue Biopharma, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity